α-Glucosidase inhibitors 0.5–0.8 Weight neutral Frequent GI side effects, three times/day dosing, expensive Exenatide 0.5–1.0 Weight loss Injections, frequent GI side effects, expensive, little ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...
New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful ...
Investigational study marks Sequel’s first pivotal data in type 2 diabetes, the largest population on insulin therapy and one of the most under-served by automated insulin delivery ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
According to the CDC, just over 1 in 10 US adults live with diabetes. What’s even more important is that more than 1 in 3 US adults are considered to have prediabetes, and 80% of those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results